Steven Mayo

Research Associate

20142019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Steven Mayo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Hemorrhage Medicine & Life Sciences
Tissue Plasminogen Activator Medicine & Life Sciences
Cerebral Hemorrhage Medicine & Life Sciences
Minimally Invasive Surgical Procedures Medicine & Life Sciences
Phase III Clinical Trials Medicine & Life Sciences
Intracranial Pressure Medicine & Life Sciences
Safety Medicine & Life Sciences
Placebos Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2014 2019

Phase III Clinical Trials
Minimally Invasive Surgical Procedures
Cerebral Hemorrhage
Tissue Plasminogen Activator
Outcome Assessment (Health Care)
Minimally Invasive Surgical Procedures
Cerebral Hemorrhage
Safety
Hemorrhage
Bacterial Infections

Enhancing the Informed Consent Process Using Shared Decision Making and Consent Refusal Data from the CLEAR III Trial

Porter, A. L., Ebot, J., Lane, K., Mooney, L. H., Lannen, A. M., Richie, E. M., Dlugash, R., Mayo, S., Brott, T. G., Ziai, W., Freeman, W. D. & Hanley, D. F., Jan 1 2019, (Accepted/In press) In : Neurocritical care.

Research output: Contribution to journalArticle

Informed Consent
Decision Making
Hemorrhage
National Institutes of Health (U.S.)
Practice Guidelines

Intracranial Hypertension and Cerebral Perfusion Pressure Insults in Adult Hypertensive Intraventricular Hemorrhage: Occurrence and Associations With Outcome

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III) Investigators, Aug 1 2019, In : Critical care medicine. 47, 8, p. 1125-1134 10 p.

Research output: Contribution to journalArticle

Cerebrovascular Circulation
Intracranial Hypertension
Intracranial Pressure
Hemorrhage
Reading

Symptomatic Hemorrhagic Complications in Clot Lysis: Evaluation of Accelerated Resolution of Intraventricular Hemorrhage Phase III Clinical Trial (CLEAR III): A Posthoc Root-Cause Analysis

Fam, M. D., Stadnik, A., Zeineddine, H. A., Girard, R., Mayo, S., Dlugash, R., McBee, N., Lane, K., Mould, W. A., Ziai, W. C., Hanley, D. F. & Awad, I. A., Dec 1 2018, In : Neurosurgery. 83, 6, p. 1260-1268 9 p.

Research output: Contribution to journalArticle

Root Cause Analysis
Phase III Clinical Trials
Hemorrhage
Tissue Plasminogen Activator
Safety